(25)
02 Junio 2016 - 3:54PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934.
|
|
|
|
|
Commission File Number
|
|
001-37423
|
|
|
|
|
Biotie Therapies Oyj
|
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
|
|
Joukahaisenkatu 6, FI-20520 Turku, Finland
|
(Address, including zip code, and telephone number, including area code, of Issuers principal executive offices)
|
|
American Depositary Shares, each representing 80
Ordinary Shares, no par value
Ordinary Shares, no par value
|
(Description of class of securities)
|
|
|
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and
registration:
¨
|
17 CFR 240.12d2-2(a)(1)
|
¨
|
17 CFR 240.12d2-2(a)(2)
|
¨
|
17 CFR 240.12d2-2(a)(3)
|
¨
|
17 CFR 240.12d2-2(a)(4)
|
¨
|
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.
|
x
|
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and
registration on the Exchange.
|
Pursuant to the requirements of the Securities Exchange Act of 1934, Biotie Therapies Oyj certifies that it
has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
|
|
June 2, 2016
|
|
|
By:
|
|
|
/s/ Timo Veromaa
|
|
|
|
CEO
|
Date
|
|
|
Name
|
|
|
|
Title
|
BIOTIE THERAPIES CORP. (NASDAQ:BITI)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
BIOTIE THERAPIES CORP. (NASDAQ:BITI)
Gráfica de Acción Histórica
De May 2023 a May 2024
Real-Time news about Biotie Therapies Corp. (MM) (NASDAQ): 0 recent articles
Más de Biotie Therapies Corp. Artículos de Noticias